The Fetal Medicine Foundation 14th World Congress in Fetal Medicine
Abstracts
 
  • Aneuploidy
  • cf DNA in maternal blood
  • Defects
    • CNS
    • Face
    • Heart
    • Lungs
    • Abdominal wall
    • GIT
    • Renal
    • Genitalia
    • Skeleton
    • High NT
    • Tumor
    • Syndromes
    • All
  • Fetal anemia
  • Impaired placentation
  • Diabetes / macrosomia
  • Preterm birth
  • Growth scan
  • Placental problems
  • Amniotic fluid abnormalities
  • Labor / delivery
  • Infections
  • Maternal
    • Maternal age
    • Obstetric cholestasis
    • Maternal death
    • Other conditions
  • Twins
  • Other

cf DNA in maternal blood

  1. Implementation of non-invasive prenatal testing for aneuploidies in Slovenia View pdf
  2. ‘CPM’ and ‘TFM’: ‘login’ and ‘password’ for decoding cfDNA based testing View pdf
  3. First trimester combined test and cfDNA testing in screening for trisomies 21, 18 and 13 View pdf
  4. Estimation of fetal fraction-based risk and redraw success rate in cases that are not callable by NIPT View pdf
  5. The impact of the introduction of cfDNA screening on CVS testing View pdf
  6. First trimester contingent screening for aneuploidies: Proposal of an algorithm View pdf
  7. NIPT present and future View pdf
  8. Сell-free DNA testing in ART pregnancies: pre-test and post-test genetic counseling View pdf
  9. Role of cfDNA testing to reduce the rates of invasive testing and maximise the detection rate View pdf
  10. Non-invasive prenatal tests: impact in portuguese pregnant population View pdf
  11. Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in IVF pregnancies View pdf
  12. Noninvasive prenatal testing: Clinical performance and counselling considerations View pdf
  13. Factors affecting fetal fraction in an Australian population View pdf
  14. Discordant result from NIPT in a phenotypical male fetus with abnormal Y chromosome in 45, X/46, XY mosaic View pdf
  15. Noninvasive prenatal testing (NIPT) for fetal trisomies in a routinely first-trimester screening View pdf
  16. An enhanced SNP-based noninvasive prenatal test reduces the failure rate of detecting aneuploidies View pdf
  17. Clinical experience with a SNP-based noninvasive prenatal test for 22q11. 2 deletion syndrome View pdf
  18. Noninvasive prenatal testing (NIPT): Is It Reliable? A Case report View pdf
  19. NIPT – is it valid for detection of Down's Syndrome caused by Robertsonian translocation? View pdf
  20. Clinical Validation of The IONA® test: A non-invasive prenatal screening test for Trisomy 21, 18 and 13 View pdf
  21. Preliminary results of contingent first trimester screening for trisomy 21 with cfDNA analysis in a Danish cohort View pdf
  22. The implementation of NIPT in the first trimester screening for Trisomy 21 in the northern region of Denmark View pdf
  23. Implementation of free fetal DNA testing as second-line screening. Factors affecting the uptake View pdf
  24. Repeated failed non-invasive prenatal testing in a woman with thrombocytopenia and APS View pdf
  25. Positive predictive value of NIPT: Assessment from the diagnostic end at the cytogenetic laboratories View pdf
  26. One clinic’s experience with cell free fetal DNA testing in Argentina View pdf
  27. Increased number of amniocentesis despite growing use of noninvasive tests in R. Macedonia View pdf
  28. Non-invasive prenatal testing for fetal submicroscopic copy number variations by maternal cfDNA sequencing View pdf
  29. First results of fetal chromosome aneuploidy testing using cell-free DNA analysis in Lithuania View pdf
  30. Noninvasive prenatal testing for pregnancies with low risks of fetal aneuploidies in a single center View pdf
11511145114311211100109610881082107610731042987951923877858848837834777759758730693677634615613612611
© 2015 The Fetal Medicine Foundation